Avalon Investment & Advisory’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-42,860
| Closed | -$7.08M | – | 377 |
|
|
2021
Q2 | $7.08M | Buy |
42,860
+1,363
| +3% | +$225K | 0.16% | 124 |
|
|
2021
Q1 | $6.36M | Buy |
41,497
+3,877
| +10% | +$594K | 0.15% | 118 |
|
|
2020
Q4 | $4.72M | Sell |
37,620
-989
| -3% | -$124K | 0.1% | 136 |
|
|
2020
Q3 | $3.92M | Sell |
38,609
-5,158
| -12% | -$523K | 0.09% | 137 |
|
|
2020
Q2 | $4.26M | Sell |
43,767
-12,940
| -23% | -$1.26M | 0.1% | 136 |
|
|
2020
Q1 | $4.71M | Sell |
56,707
-4,178
| -7% | -$347K | 0.12% | 141 |
|
|
2019
Q4 | $6.77M | Buy |
60,885
+692
| +1% | +$76.9K | 0.14% | 134 |
|
|
2019
Q3 | $5.97M | Sell |
60,193
-780
| -1% | -$77.4K | 0.13% | 135 |
|
|
2019
Q2 | $6.05M | Buy |
60,973
+27,942
| +85% | +$2.77M | 0.13% | 139 |
|
|
2019
Q1 | $3.64M | Sell |
33,031
-19,187
| -37% | -$2.12M | 0.08% | 161 |
|
|
2018
Q4 | $4.8M | Buy |
52,218
+2,572
| +5% | +$237K | 0.12% | 143 |
|
|
2018
Q3 | $5.47M | Buy |
49,646
+3,489
| +8% | +$384K | 0.15% | 157 |
|
|
2018
Q2 | $4.31M | Buy |
46,157
+21,893
| +90% | +$2.04M | 0.13% | 157 |
|
|
2018
Q1 | $2.01M | Buy |
24,264
+2,199
| +10% | +$182K | 0.06% | 212 |
|
|
2017
Q4 | $2.01M | Buy |
22,065
+1,106
| +5% | +$101K | 0.06% | 201 |
|
|
2017
Q3 | $1.6M | Sell |
20,959
-134
| -0.6% | -$10.2K | 0.05% | 200 |
|
|
2017
Q2 | $1.58M | Buy |
21,093
+2,695
| +15% | +$202K | 0.05% | 202 |
|
|
2017
Q1 | $1.2M | Buy |
+18,398
| New | +$1.2M | 0.04% | 235 |
|